Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Groffik, A. [1 ]
Mueller-Brenne, T. [1 ]
Rudolph, B. [1 ]
Rietz, S. [1 ]
Grabbe, S. [1 ]
Loquai, C. [1 ]
机构：
[1] Univ Med Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [1] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [2] Long-term Survival in Metastatic Malignant Melanoma: Ipilimumab Followed by Vemurafenib in a Patient with Brain Metastasis
    Balakan, Ozan
    Suner, Ali
    Yigiter, Remzi
    Balakan, Tuba
    Sirikci, Akif
    Sevinc, Alper
    INTERNAL MEDICINE, 2012, 51 (19) : 2819 - 2823
  • [3] Vemurafenib in patients with metastatic malignant melanoma.
    Ocvirk, Janja
    Mesti, Tanja
    Boc, Marko
    Rebersek, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb).
    Galli, Giulia
    Di Guardo, Lorenza
    Cimminiello, Carolina
    Cavalieri, Stefano
    Rodolfo, Monica
    Rivoltini, Licia
    Valeri, Barbara
    Bono, Aldo
    Tolomio, Elena
    Del Vecchio, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA
    COATES, AS
    SEGELOV, E
    ANNALS OF ONCOLOGY, 1994, 5 (03) : 249 - 251
  • [6] Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications
    Mandel, Victor Desmond
    Medri, Matelda
    Manganoni, Ausilia Maria
    Pavoni, Laura
    De Rosa, Francesco
    Ribero, Simone
    Foca, Flavia
    Andreis, Daniele
    Mazzoni, Laura
    Magi, Serena
    Farnetani, Francesca
    Palla, Marco
    Ulivi, Paola
    Stanganelli, Ignazio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1368 - 1375
  • [7] Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib
    Sachpekidis, Christos
    Hassel, Jessica C.
    Dimitrakopoulou-Strauss, Antonia
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2017, 20 (03): : 251 - 253
  • [8] DRESS under a targeted Combination Therapy with Vemurafenib and Cobimetinib in Patients with metastatic malignant Melanoma
    Gschnell, M.
    Pickert, J.
    Logenthiran, L.
    Bender, A.
    Pfuetzner, W.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 42 - 43
  • [9] Long-term therapeutic success of sequential immunotherapy and targeted therapy in metastatic malignant melanoma
    Rudolph, V.
    Leven, A. S.
    Peller, V.
    Mueller, C.
    Scheib, C.
    Zillikens, H.
    Roesch, A.
    Ugurel, S.
    Schadendorf, D.
    Zimmer, L.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 47 - 48
  • [10] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Takeshi Fukumoto
    Susumu Fujiwara
    Masanobu Sakaguchi
    Masahiro Oka
    Naomi Kiyota
    Yasuo Ejima
    Koichi Nakajima
    Chikako Nishigori
    European Journal of Dermatology, 2017, 27 : 177 - 178
12345